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Secondary metabolites are often highly biologically active molecules and are widely used from antibacterial
to anticancer drugs. In this issue of Chemistry and Biology, Zaehle and coworkers describe the gene cluster
and biosynthesis of the polyketide terrein, a secondary metabolite produced by the soil-borne fungus
Aspergillus terreus.The discovery and subsequent medicinal
use of antibacterial compounds such as
sulfonamides and penicillin represent a
major revolution in medicine and public
health and thereby a milestone in human
history. Many bacterial infections, which,
in previous times, often caused the death
of the patients and even resulted in
several worldwide epidemies, suddenly
could be cured. Whereas sulfonamides
are of a chemical origin, penicillin is a
typical fungal product. Many microorgan-
isms produce a large variety of so-called
secondary metabolites, which do not
play an obvious role in their primary meta-
bolism but may serve important functions
for the survival in their natural habitats.
Meanwhile, thousands of such com-
pounds have been described, and some
of them are of tremendous value for us
as antibiotics (b-lactam antibiotics, eryth-
romycin, and tetracyclin), immunosup-
pressives (rapamycin), anticancer (epo-
thilone B) or anti-cholesterol drugs
(lovastatin). Indeed, there is a great inter-
est to find novel compounds to combat
multidrug-resistant bacteria (von Nuss-
baum et al., 2006).
Huge compound screening programs
have been employed in the past to identify
novel molecules and then test their
pharmacological potential. This period
was followed by a period where rational
design was favored and screening for
novel compounds was somehow ne-
glected. Nowadays ‘‘omics’’approaches
give new impetus to drug discovery and
compound characterization. The article
by Zaehle et al. (2014) in this issue
of Chemistry & Biology is a beautifulexample of how genomics, genetics,
molecular biology, biochemistry, syn-
thetic biology, and toxicology are nowa-
days combined for the analysis of fungal
secondary metabolites.
The molecule studied in the article by
Zaehle et al. (2014), terrein, belongs to
the group of polyketides in whose biosyn-
thesis a polyketide synthase is the key
enzyme. Polyketide synthases (PKSs) are
large, multidomain enzymes or enzyme
complexes that produce an extraordinary
complex variety of natural products start-
ing from small acids, such as acetyl-
CoA, propionyl-Co, buturyl-CoA, and
derivatives (Khosla et al., 2014). With sim-
ilarities to fatty acid synthase, the short
building blocks condense, accompanied
by decarboxylation, to complicated mole-
cules. Despite many similarities to fatty
acid synthesis, a significant difference
is the fact that, during fatty acid bio-
synthesis, the final molecule is largely
reduced, whereas the building blocks
of polyketides may remain in the oxida-
tive state and can thus be easily further
modified. Another difference concerns
the building blocks itself. Although each
PKS is thought to be specific for one spe-
cific polyketide, there are cases where
different starting blocks or building blocks
for the extension can be used. Thus, the
promiscuity of a PKS to produce different
chain lengths along with the reactivity of
the end products of the PKS reaction
results in the enormous variety of natural
secondary metabolites.
Thousands of secondary metabolites
have been described to date. Molecular
analysis of their biosynthesis revealedChemistry & Biology 21, June 19, 2014that the genes are normally clustered in
the genome (Keller et al., 2005). Hundreds
of such gene clusters have been identi-
fied, meanwhile, in the course of genome
annotations. However, the link between
the compounds and the biosynthetic
gene clusters responsible for their biosyn-
theses is largely missing. In addition,
many gene clusters are not expressed un-
der laboratory conditions and need to be
activated in order to identify further sec-
ondary metabolites (Wiemann and Keller,
2014). One approach to assign a function
to a certain PKS or the entire gene cluster
is a gene deletion or silencing strategy
with subsequent metabolic profiling of
the mutant strains (Saha et al., 2012).
This has been applied by Zaehle et al.
(2014) to identify the gene cluster respon-
sible for terrein biosynthesis in the com-
mon soil-borne fungus Aspergillus terreus
(Figure 1). The compound itself was
chemically described 80 years ago,
and the structure was resolved in 1954
(Grove, 1954; Barton and Miller, 1955).
Previous classical stable-isotope labeling
experiments suggested that five acetate
molecules condensed to form the mole-
cule, although the formula implies that
it is composed of only four acetates
(eight C-atoms). This riddle has been
solved by Zaehle et al. (2014). Deletion
of several of the terA gene cluster genes
in combination with 13C-glucose feeding
experiments allowed the authors to
identify 6-hydroxymellein (ten C atoms)
as an intermediate. The alternation of
labeled and unlabeled carbon atoms
in 6-hydroxmellein can be explained
by the condensation of one acetyl- andª2014 Elsevier Ltd All rights reserved 701
Figure 1. The Minimal Terrein Biosynthesis Gene Cluster of
Aspergillus terreus Represents the Typical Arrangement for
Secondary Metabolite Genes
A pathway-specific regulator controls the expression of the other genes
involved in the biosynthesis. The central enzyme of many secondary metabo-
lites is the multidomain-containing polyketide synthase consisting of a starter
acyltransferase (SAT), a ketoacyl synthase (KS), an acyltransferase (AT), a
product template (PT), two acyl carrier protein domains (ACP), and a thio-
esterase domain (TE). In the case of terrein biosynthesis two, three, or four
malonate-CoA molecules can be added as building blocks, resulting in three
different products. Multidisciplinary approaches are now well established to
discover novel secondary metabolites and characterize their structure and
function.
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Previewsfour malonyl-Co residues. In
terrein, two adjacent carbon
atoms were nonlabeled, sug-
gesting decarboxylation and
ring contraction of 6-hydro-
xymellein. This is, thus, a
beautiful example of how ge-
netics in combination with
isotope-labeling and struc-
tural chemistry methods,
such as high-resolution mass
spectrometry and nuclear
magnetic resonance, com-
plement each other to unravel
biochemical pathways.
In a synthetic biology
approach, the authors ex-
pressed the PKS in a different
filamentous fungus, A. niger,
and were able to identify
several products formed by
this PKS, although only one
of them is apparently further
converted to the final prod-
uct, terrein. The fate of the
other two PKS products re-
mains elusive. However, it is
possible that these twomole-
cules are further transformed
into other secondary metab-
olites, and, thus, this in the
first view nonproductive
catalysis could contribute to
the diversity of secondary
metabolites.
Last but not least, the
article adds to the knowledgeof potential functions of secondary
metabolites in nature. Although it was
described that terrein has antibacterial,
antifungal, anti-inflammatory, antioxida-
tive, antiproliferative, proapoptotic prop-
erties, it was only in 2007 that the plant-
growth inhibiting function of terrein was
recognized. Zaehle et al. (2014) now
show that this polyketide causes lesions
on fruit surfaces. This phytotoxic activity
could be of vital importance in the strug-
gle for nutrients in nature and thus could
add to the scarce knowledge of the bio-
logical function of secondary metabolites.
The identification of the terrein biosyn-
thesis gene cluster has several important
aspects. Because A. terreus is a common702 Chemistry & Biology 21, June 19, 2014 ªsoil-borne fungus, contaminates feed and
food, and is also an emerging pathogen,
the monitoring of the potentially toxic
terrein is highly desirable. The knowledge
of the terrein gene cluster opens new
avenues for RNA-based detection
methods for gene expression long before
the compound can be detected (Schmidt-
Heydt and Geisen, 2007). In addition, the
knowledge of the genes encoding the
enzymes for terrein biosynthesis allows
further synthetic biology approaches to
modify the final product and thereby
perhaps change the biological activities.
Next steps should, of course, be the eluci-
dation of the exact mode of action and the
molecular target to explain the observed2014 Elsevier Ltd All rights reservedactivities and evaluate the
potential uses of terrein or de-
rivatives thereof.
Whereas serendipity led to
the discovery of the first sec-
ondary metabolite with high
commercial value, penicillin,
recent approaches aim at
systematic screening pro-
grams, the waking up of
secondary metabolite gene
clusters, and designer drugs
by rationally reprogramming
through combinatorial manip-
ulation (Chiang et al., 2013;
Unkles et al., 2014). However,
as yet shown for several poly-
ketide synthases, enzyme
promiscuity may be important
in the playground of nature,
and thus understanding pro-
miscuity may help to develop
novel man-made drugs.
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